Cognitive-Enhancing Cognizin Citicoline Found to Improve Motor Speed and Attention in Adolescents
Recently unveiled at the annual American Society of Clinical Psychopharmacology conference in Hollywood, Florida, a new randomized, double-blinded, placebo-controlled human clinical trial conducted by the Brain Institute, at the University of Utah, found that adolescent males experienced increased motor speed and attention after supplementation of Cognizin brand citicoline (CDP-Choline). The trial involved 75 adolescent males over a 28-day period in which the citicoline, a known cognition-enhancing nutrient, was administered. The research reported that the individuals who were administered citicoline showed multiple improved cognitive domains, which includes measures of attention and motor speed.









0 Comments